Carcinoma, Pancreatic Ductal Clinical Trials in Lille
2 recruitingLille, France
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
PrognosisCarcinoma, Pancreatic Ductal
Institut Curie85 enrolled7 locationsNCT05475366
Recruiting
Phase 2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc.260 enrolled89 locationsNCT05968326